{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
MDA
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Live Events
  • Online Courses
  • Regularly Scheduled Series
  • Non-Accredited Courses
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

MD Anderson workforce members:  Select "MD ANDERSON LOGIN" and enter your MD Anderson email address and password.

Guests (all other than MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:



Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##






Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =


  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD

Please enter your degree:





Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Statewide Lymphoma Virtual Grand Rounds


RSS

  • Overview
  • Faculty
  • Schedule
Add to Calendar Statewide Lymphoma Virtual Grand Rounds 4/28/2023 12:00:00 PM 4/28/2023 1:00:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/course/courseoverview?P=0&EID=31144 Description: The intent is for the learners to build a collaborative community of practice, sharing best evidence, up-to-date results of new FDA approved treatments or latest or newly published clinical trials, to influence treatment decisions for patients in the state of Texas diagnosed with lymphomas. MD Anderson - Virtual false MM/DD/YYYY


Date & Location
Occurs monthly on the 3rd Friday starting on 4/28/2023 at 12:00 PM
Friday, April 28, 2023, 12:00 PM - 1:00 PM, MD Anderson - Virtual, Houston, TX

Target Audience
Specialties - Hematology, Medical Oncology, Pathology, Radiation Oncology
Professions - Other, Physician (MD or DO), Student or Trainee

Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Overview
The intent is for the learners to build a collaborative community of practice, sharing best evidence, up-to-date results of new FDA approved treatments or latest or newly published clinical trials, to influence treatment decisions for patients in the state of Texas diagnosed with lymphomas.


Objectives
At the conclusion of this activity, learners will be able to:

  1. Present a general overview of lymphoid malignancies.
  2. Highlight recent updates and treatment strategies in lymphoma.
  3. Disseminate knowledge and change behavior of clinicians to improve lymphoma patient outcomes

Registration

If you are interested in attending this series, contact Lisa Foucheaux-Heider at 713.745.4247 [email protected]

 


Accreditation

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.





Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 




The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.



Mitigation of Relevant Financial Relationships


The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Faculty Member Information
Role in activity
Name of Ineligible Company(s) / Nature of Relationship(s)
Sairah Ahmed, MD
associate professor
MDACC
Activity Co-Director
Grant or research support-Seattle Genetics, Inc.|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Xencor|Grant or research support-Tessa Therapeutics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Myeloid|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Servier Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Tessa Therapeutics
Maria Alma Rodriguez, MD, MACP
Professor, Lymphoma-Myeloma
The University of Texas MD Anderson Cancer Center
Activity Director
Nothing to disclose
Yaser Alkhatib, Md
MDACC
Other Planning Committee Member
Nothing to disclose
Farrukh Awan, MD
Professor of Medicine
UT Southwestern Medical Center
Other Planning Committee Member
Consulting Fee-AbbVie Inc.|Consulting Fee-Celgene Corporation (Relationship has ended)|Consulting Fee-AstraZeneca US|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Beigene|Consulting Fee-Genentech, Inc. (Relationship has ended)|Consulting Fee-Janssen Biotech, Inc.|Consulting Fee-Johnson & Johnson (any division)|Consulting Fee-Pharmacyclics LLC|Grant or research support-Pharmacyclics LLC|Consulting Fee-Gilead Sciences, Inc. (Relationship has ended)|Consulting Fee-Kite Pharma (Relationship has ended)|Consulting Fee-Karyopharm (Relationship has ended)|Consulting Fee-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Consulting Fee-MEI Pharma (Relationship has ended)|Consulting Fee-Verastem (Relationship has ended)|Consulting Fee-Incyte Corporation (Relationship has ended)|Consulting Fee-Dava Oncology|Consulting Fee-Cardinal Health (Relationship has ended)|Consulting Fee-ADCT therapeutics (Relationship has ended)|Consulting Fee-Epizyme, Inc. (Relationship has ended)|Consulting Fee-Caribou Biosciences (Relationship has ended)|Consulting Fee-Cellecter Bisosciences (Relationship has ended)|Consulting Fee-Loxo Oncology|Consulting Fee-Adaptive Biotechnologies (Relationship has ended)
Akiva Diamond, MD
Assistant Professor
Baylor College of Medicine
Other Planning Committee Member
Nothing to disclose
Siddhartha Ganguly, MD
Dr.
Houston Methodist Hospital and Neal Cancer Center
Other Planning Committee Member
Honoraria-AstraZeneca US (Relationship has ended)|Speakers Bureau-Gilead Sciences, Inc.|Honoraria-Bristol-Myers Squibb Company (Relationship has ended)|Honoraria-Sanofi Genzyme (Relationship has ended)
Premal Lulla, MD
Associate Professor
Baylor College of Medicine
Other Planning Committee Member
Nothing to disclose
Courtney Miller-Chism, MD
Baylor College of Medicine
Other Planning Committee Member
Nothing to disclose
Faculty Photos
Loretta J. Nastoupil, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Other Planning Committee Member
Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Janssen Biotech, Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-Takeda|Honoraria-ADC Therapeutics (Relationship has ended)|Grant or research support-Genmab|Honoraria-MEI |Honoraria-Atara (Relationship has ended)|Grant or research support-Epizyme, Inc.
Adan Rios, MD
Adan Rios
U Texas Medical School
Other Planning Committee Member
Nothing to disclose

Sort by: Date Name

Date Empty Column Title
    No activities are currently published for this month.
No upcoming dates have been setup.

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2022 The University of Texas MD Anderson Cancer Center
See us on Facebook See us on Twitter See us on Linked In See us on Instagram